Thomas E. Oland is the CEO of Bio-Techne, a company known for its contributions to the life sciences industry. He has been with Bio-Techne since 1985, growing the company from a smaller entity into a significant player in biotechnology. Oland...
Thomas E. Oland is the CEO of Bio-Techne, a company known for its contributions to the life sciences industry. He has been with Bio-Techne since 1985, growing the company from a smaller entity into a significant player in biotechnology. Oland is also notable for his hands-on approach to leadership, having previously founded R&D Systems, a subsidiary of Bio-Techne. Throughout his career, he has emphasized aligning executive compensation with company performance, ensuring that the company’s leadership focuses on achieving strategic goals like revenue growth and profitability. Oland has a reputation for waiving bonuses; for instance, in several years, he chose not to take bonuses despite the company reaching record revenues. His insider trading record shows substantial fluctuations in his holdings, with a notable increase in value from around $310 million to over $1.4 billion in a short period. His long tenure and deep understanding of the industry make him a key figure in shaping Bio-Techne's direction. Oland's strategy emphasizes performance-driven growth in stock value, establishing a culture of accountability and success within the company.